The real-world tolerability and efficacy of asparaginase in adults aged 40 years and older with Philadelphia-negative acute lymphoblastic leukemia
- Resource Type
- Authors
- Simon Wu; Christian E Bryant; Andrew Grigg; Ing Soo Tiong; Mridula Mokoonlall; Anthony P. Schwarer; Caroline Dix; James D'Rozario; Matthew J Rees
- Source
- Leukemialymphoma. 62(10)
- Subject
- Oncology
Adult
Cancer Research
medicine.medical_specialty
Asparaginase
Lymphoblastic Leukemia
Antineoplastic Agents
chemistry.chemical_compound
hemic and lymphatic diseases
Internal medicine
medicine
Humans
Philadelphia Chromosome
Philadelphia negative
Adult all
business.industry
Hematology
Middle Aged
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Tolerability
chemistry
Feature (computer vision)
Acute Disease
business
- Language
- ISSN
- 1029-2403
Pediatric-inspired acute lymphoblastic leukemia (ALL) regimens are increasingly used in adult ALL [1]. These protocols universally feature asparaginase (ASP), a bacterial enzyme which deprives ALL ...